Background: To gain maximum therapeutic effect while minimizing side effects, it is
imperative for patients with hypothyroidism to use their levothyroxine (LT4) correctly, such as …

Background: The prevalence of hypothyroidism (HT) has increased over time. To assess the
effectiveness of treatment, we (1) studied thyrotropin (TSH) levels among patients receiving …

Abstract Background The CONTROL Surveillance Project was a comprehensive patient-
based survey conducted among hypothyroid patients undergoing treatment. The primary …

Background: A significant number of patients show sub-optimal adherence to levothyroxine
(LT4) therapy, mainly because they have to postpone their breakfast by at least 30 min. The …

Context: Levothyroxine (LT4) monotherapy is the standard of care for hypothyroidism.
Objective: To determine whether LT4 at doses that normalize the serum TSH is associated …

Aim To describe practices of French physicians regarding thyroid hormone therapy, focusing
on available LT4 formulations. Material and methods Members of the French Endocrine …

Lifelong treatment with levothyroxine (LT4) is the mainstay of management for individuals
with hypothyroidism. Many hypothyroid patients start LT4 treatment at a low dose (eg 25–50 …

Objective A decrease over time in thyroid stimulating hormone (TSH) levels when initiating
levothyroxine (L-T4) therapy for hypothyroidism has been reported, where treatment most …

Introduction Patients may be symptomatic, resulting in lower quality of life (QOL), despite L-
thyroxine (LT4) therapy for hypothyroidism or having normal thyroid function. We …

Objective A great number of factors can interfere with levothyroxine (LT4) tablet absorption,
leading to increased serum thyroid-stimulating hormone (TSH) levels and, accordingly, to …